StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Emmaus Life Sciences's total debt was $800.00K at Dec 31, 2021. For fiscal 2021 it was $800.00K, up 2447.8% from the year before. The highest annual figure on record is $800.00K in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$800.00K+2447.8%
FY2016Sep 30, 2016$31.40K+797.1%
FY2014Sep 30, 2014$3.50K-51.4%
FY2013Sep 30, 2013$7.20K+38.5%
FY2012Sep 30, 2012$5.20K-14.8%
FY2011Sep 30, 2011$6.10K-77.3%
FY2010Sep 30, 2010$26.90K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2021CQ4 2021Dec 31, 2021$800.00K+4633.7%
Q3 FY2019CQ3 2018Jun 30, 2019$615.80K+1861.1%
Q2 FY2019CQ2 2018Mar 31, 2019$606.50K+17738.2%
Q2 FY2017CQ1 2017Mar 31, 2017$2.00K-39.4%
Q1 FY2017CQ4 2016Dec 31, 2016$16.90K–
Q4 FY2016CQ3 2016Sep 30, 2016$31.40K–
Q2 FY2015CQ1 2015Mar 31, 2015$3.40K–
Q1 FY2015CQ4 2014Dec 31, 2014$3.30K–

More Emmaus Life Sciences figures

See a number that looks wrong?